GSK to stop selling blood cancer drug Blenrep in US
The company had said this month that Blenrep had failed the main goal of a key study designed to show it was better than an…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
BLENREP
GSK to acquire Sierra Oncology to shore up drug pipeline
The acquisition is expected to close in the third quarter and will complement Blenrep, GSK’s treatment for another form of blood…
GSK gets USFDA approval for BLENREP to treat relapsed or refractory multiple myeloma
BLENREP is the fifth major medicine approval for GSK in 2020